Study of management of preterm labor in India
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Preterm Labor
- Registration Number
- CTRI/2017/04/008307
- Lead Sponsor
- Abbott India Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 285
Inclusion Criteria
Adult women with spontaneous preterm labor (between 24 and 37 weeks of gestation) as diagnosed by the physician and admitted/treated at the study centre in between 1st Jan 2014 to 31st Dec 2016
Exclusion Criteria
Women with known short cervix maintained on tocolytics
2. Women with preterm premature rupture of membranes, triplet and higher-order multifetal pregnancy and those with a fetal structural or genetic anomaly
3. Patients with incomplete hospital records (missing notes, reports or any other important data required for the study)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To determine the clinical and obstetric characteristics of patients with preterm labor <br/ ><br>2.To determine the pharmacological treatments used in the management of preterm laborTimepoint: At the end of study
- Secondary Outcome Measures
Name Time Method 1.To determine the success of different pharmacological treatments in terms of maternal outcomes (tocolysis and prolongation of pregnancy) and neonatal outcomes <br/ ><br>2.To determine the latency period with different pharmacological treatments <br/ ><br>3. To assess side effects of different pharmacological treatmentsTimepoint: At the end of study